Related Experiment Video
Updated: Jul 11, 2025

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
Elevated matrix metalloproteinase‑9 expression is associated with COVID‑19 severity: A meta‑analysis
Ling Ding1,2, Haipeng Guo1,2, Chao Zhang1,2
1Department of Laboratory Medicine, The First Hospital of Qiqihar, Qiqihar, Heilongjiang 161005, P.R. China.
Insights
Serum matrix metalloproteinase-9 (MMP-9) levels are elevated in severe COVID-19 cases and associated with complications like ARDS. Higher MMP-9 indicates increased disease severity and potential therapeutic targets for COVID-19 patients.
Area of Science:
- Biochemistry
- Immunology
- Infectious Diseases
Background:
- Coronavirus Disease 2019 (COVID-19) poses significant global health challenges.
- Understanding biomarkers for COVID-19 severity is crucial for patient management.
- Matrix metalloproteinase-9 (MMP-9) is implicated in inflammatory processes.
Purpose of the Study:
- To evaluate the clinical significance of serum MMP-9 levels in COVID-19 patients.
- To correlate MMP-9 levels with disease severity and patient outcomes.
Main Methods:
- A meta-analysis of 12 studies involving 2,062 COVID-19 patients.
- Searched databases including PubMed, Web of Science, EMBASE, Cochrane, WANFANG, and CNKI.
- Compared serum MMP-9 levels across different patient subgroups (severe vs. non-severe, ARDS vs. non-ARDS, survivors vs. non-survivors, etc.).
Main Results:
- Serum MMP-9 levels were significantly higher in severe COVID-19 patients compared to non-severe cases.
- Elevated MMP-9 levels were observed in patients with Acute Respiratory Distress Syndrome (ARDS).
- Higher MMP-9 levels were also noted in patients with neurological syndromes and obese diabetic patients.
Conclusions:
- Serum MMP-9 levels are significantly associated with COVID-19 severity.
- MMP-9 may serve as a potential biomarker for predicting COVID-19 progression.
- Targeting MMP-9 could be a therapeutic strategy for improving COVID-19 patient prognosis.
Abstract:
The present meta-analysis investigated the clinical value of serum matrix metalloproteinase (MMP)-9 levels in Coronavirus Disease 2019 (COVID-19) patients. Studies assessing the outcomes of patients with COVID-19 in correlation with the MMP-9 levels were retrieved from PubMed, Web of Science, EMBASE, Cochrane, WANFANG, and CNKI. A meta-analysis was performed to compare the serum MMP-9 levels between different patient groups: Severe vs. non-severe; acute respiratory distress syndrome (ARDS) vs. non-ARDS; non-survivors vs. survivors; neurologic syndrome vs. non-neurologic syndrome; and obese diabetic vs. non-obese diabetic. A total of 2,062 COVID-19-confirmed patients from 12 studies were included in this meta-analysis. The serum MMP-9 levels were significantly higher in patients with severe COVID-19 than in those with non-severe COVID-19 [weighted mean difference (WMD) 246.61 (95% confidence interval (CI), 115.86-377.36), P<0.001]. Patients with ARDS exhibited significantly higher MMP-9 levels than those without ARDS [WMD 248.55 (95% CI, 63.84-433.25), P<0.001]. The MMP-9 levels in the non-survivors did not significantly differ from those in the survivors [WMD 37.79 (95% CI, -18.08-93.65), P=0.185]. Patients with comorbidities, including neurological syndromes, and obese diabetic patients had significantly higher MMP-9 levels than those without comorbidities [WMD 170.73 (95% CI, 95.61-245.85), P<0.001]. Serum MMP-9 levels were associated with COVID-19 severity and may serve as a therapeutic target for improving the prognosis of patients with COVID-19.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Overview of Cell-Matrix Interactions

